SEARCH

SEARCH BY CITATION

Keywords:

  • ghostwriting;
  • honorary authors;
  • medical ethics;
  • pharmaceutical companies;
  • plagiarism;
  • public health;
  • research misconduct

ABSTRACT

This paper focuses on medical ghostwriting in the United States. I argue that medical ghostwriting often involves plagiarism and, in those cases, can be treated as an act of research misconduct by both the federal government and research institutions. I also propose several anti-ghostwriting measures, including: 1) journals should implement guarantor policies so that researchers may be better held accountable for their work; 2) research institutions and the federal government should explicitly prohibit medical ghostwriting and outline appropriate penalties; and 3) a publicly available database should be created to record researchers' ethics violations.